Søgeresultater - Greuter, Marjolein J.E.
- Showing 1 - 11 results of 11
-
1
Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program af Vleugels, Jasper L. A., Greuter, Marjolein J. E., Hazewinkel, Yark, Coupé, Veerle M. H., Dekker, Evelien
Udgivet 2017Text -
2
-
3
Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening af Bronzwaer, Maxime E. S., Greuter, Marjolein J. E., Bleijenberg, Arne G. C., IJspeert, Joep E. G., Dekker, Evelien, Coupé, Veerle M. H.
Udgivet 2018Text -
4
Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients af Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Udgivet 2020Text -
5
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients af Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Udgivet 2021Text -
6
The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis af Greuter, Marjolein J E, Berkhof, Johannes, Fijneman, Remond J A, Demirel, Erhan, Lew, Jie-Bin, Meijer, Gerrit A, Stoker, Jaap, Coupé, Veerle M H
Udgivet 2016Text -
7
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data af Jongeneel, Gabrielle, Klausch, Thomas, van Erning, Felice N., Vink, Geraldine R., Koopman, Miriam, Punt, Cornelis J.A., Greuter, Marjolein J.E., Coupé, Veerle M.H.
Udgivet 2019Text -
8
Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study af Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Twisk, Jos W. R., Koopman, Miriam, Punt, Cornelis J. A., Vink, Geraldine R., Coupé, Veerle M. H.
Udgivet 2021Text -
9
Early cost-effectiveness analysis of risk-based selection strategies for adjuvant treatment in stage II colon cancer: the potential value of prognostic molecular markers af Jongeneel, Gabrielle, Greuter, Marjolein J.E., Kunst, Natalia, van Erning, Felice N., Koopman, Miriam, Medema, Jan P., Vermeulen, Louis, Ijzermans, Jan N.M., Vink, Geraldine R., Punt, Cornelis J.A., Coupé, Veerle M.H.
Udgivet 2021Text -
10
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study af van Wifferen, Francine, de Jonge, Lucie, Worthington, Joachim, Greuter, Marjolein J.E., Lew, Jie-Bin, Nadeau, Claude, van den Puttelaar, Rosita, Feletto, Eleonora, Yong, Jean H.E., Lansdorp-Vogelaar, Iris, Canfell, Karen, Coupé, Veerle M.H.
Udgivet 2022Text -
11
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN) af Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Medema, Jan P., Kandimalla, Raju, Goel, Ajay, Bujanda, Luis, Meijer, Gerrit A., Fijneman, Remond J. A., van Oijen, Martijn G. H., Ijzermans, Jan, Punt, Cornelis J. A., Vink, Geraldine R., Coupé, Veerle M. H.
Udgivet 2020Text